These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7705796)

  • 21. Detection of Wilson's disease in sibs of a patient with Wilson's disease.
    Kamoun P; Cadoudal M; Rabier D; Jérôme H
    Clin Chem; 1986 Feb; 32(2):392. PubMed ID: 3943210
    [No Abstract]   [Full Text] [Related]  

  • 22. Wilson's disease: identification of an abnormal copper-binding protein.
    Evans GW; Bubois RS; Hambidge KM
    Science; 1973 Sep; 181(4105):1175-6. PubMed ID: 4726442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
    Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
    Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper dynamics in Wilson's disease.
    Osborn SB; Walshe JM; Williams R
    Ann Biol Clin (Paris); 1972; 30(4):391-6. PubMed ID: 5082973
    [No Abstract]   [Full Text] [Related]  

  • 25. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
    Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
    [No Abstract]   [Full Text] [Related]  

  • 26. Wilson's disease patients can be decoppered.
    Walshe JM
    Lancet; 1989 Jul; 2(8656):228. PubMed ID: 2568563
    [No Abstract]   [Full Text] [Related]  

  • 27. Intrahepatocellular localization of copper in Wilson's disease.
    Yano M; Sakamoto N; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport.
    Osborn SB; Walshe JM
    Clin Sci; 1965 Dec; 29(3):575-81. PubMed ID: 5848709
    [No Abstract]   [Full Text] [Related]  

  • 29. Hereditary iron and copper deposition: diagnostics, pathogenesis and therapeutics.
    Aaseth J; Flaten TP; Andersen O
    Scand J Gastroenterol; 2007 Jun; 42(6):673-81. PubMed ID: 17505988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wilson's disease and copper-associated protein.
    Lancet; 1981 Mar; 1(8221):644-6. PubMed ID: 6110867
    [No Abstract]   [Full Text] [Related]  

  • 31. Is copper incorporation to caeruloplasmin normal in Wilson's disease?
    Chowrimootoo GF; Seymour CA
    Biochem Soc Trans; 1994 May; 22(2):191S. PubMed ID: 7958254
    [No Abstract]   [Full Text] [Related]  

  • 32. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 34. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Minerals in normal and cirrhotic liver. The pathology of mineral dependent athrocytic liver cirrhosis].
    Brandt G; Spitzer F
    Leber Magen Darm; 1978 Dec; 8(6):343-6. PubMed ID: 739812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future therapy in haemochromatosis and Wilson's disease.
    Murray KF; Lam D; Kowdley KV
    Expert Opin Pharmacother; 2003 Dec; 4(12):2239-51. PubMed ID: 14640923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.
    Dusek P; Roos PM; Litwin T; Schneider SA; Flaten TP; Aaseth J
    J Trace Elem Med Biol; 2015; 31():193-203. PubMed ID: 24954801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilson's disease and hepatocellular carcinoma: possible protective role of copper.
    Wilkinson ML; Portmann B; Williams R
    Gut; 1983 Aug; 24(8):767-71. PubMed ID: 6307837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
    Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
    Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.